Proton Pump Inhibitor Litigation
According to the JPML's Order, there are currently 14 proton pump inhibitor lawsuits pending in 11 federal districts. All were filed on behalf of individuals who developed chronic kidney disease, kidney failure, acute interstitial nephritis and other renal problems allegedly related to their use of Nexium, Prilosec, PrevAcid and other medications in this class. Plaintiffs' accuse the drugs' manufacturers of concealing information linking proton pump-inhibitors to an increased risk of serious kidney complications and failing to warn the public about these potential side effects. The lawsuits also cite a growing body of research linking the extended use of proton pump inhibitors to kidney injuries. These studies include one published this past April in the Journal of the American Society of Nephrology which reported that long-term users may be 96% more likely to develop kidney failure and 28% more likely to develop chronic kidney disease compared to patients taking another class of heartburn drugs called H2-blockers.
Proton pump inhibitor plaintiffs motioned for the creation of a multidistrict litigation in October, asserting that centralization of the federal docket will allow for the efficient prosecution of what could eventually be thousands of similar cases. They have proposed that the proceeding be established in the U.S. District Court, District of New Jersey, or alternatively, the District of New Jersey, the Southern District of Illinois, the District of Kansas or the Western District of Louisiana. If the JPML agrees to create a multidistrict litigation, all of the proton pump inhibitor cases now pending in federal court, as well as any filed in the future, will be transferred to the litigation for coordinated pretrial proceedings, including motion practice and discovery.
Individuals who were diagnosed with serious kidney complications following treatment with Nexium or another proton pump inhibitor may be entitled to compensation for medical bills, lost wages, pain and suffering, and any other injury-related damages they incurred. To learn more about filing a Nexium lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nexium-lawsuit-news-centralization-of-proton-pump-inhibitor-kidney-claims-to-be-addressed-by-jpml-in-january-bernstein-liebhard-llp-reports-300379877.html
SOURCE Bernstein Liebhard LLP